Company intelligence / Profile preview

Jenfer Biosciences

Charleston, South Carolina, United States

Ownership: Private
Development stage: Other

Overview

Jenfer Biosciences is a pre-clinical stage biotechnology company focused on developing innovative cancer therapeutics. The company's primary research centers on targeting the xCT cystine/glutamate transporter, a key component in maintaining redox balance within cancer cells. By inhibiting this transporter, Jenfer aims to induce ferroptosis and oxidative stress specifically in nutrient-dependent tumors such as triple-negative breast cancer. Their lead programs are designed to exploit metabolic vulnerabilities in aggressive cancers that have limited treatment options.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jenfer Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jenfer Biosciences.

Explore the full profile